Monte Rosa Therapeutics, Inc.

Ownership Transactions Reported by 33 Insiders

Symbol
GLUE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
321 Harrison Avenue, Suite 900, Boston, Massachusetts

Insiders trading volume in the past year

Monte Rosa Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Versant Venture Capital VI, L.P. 10%+ Owner $169 M Jun 28, 2021
Bradley J. Bolzon PhD Director, 10%+ Owner $169 M Jun 28, 2021
Paul Edward Walker 10%+ Owner $146 M Jun 28, 2021
Liza Landsman 10%+ Owner $146 M Jun 28, 2021
Carmen Chang 10%+ Owner $146 M Jun 28, 2021
Scott D. Sandell 10%+ Owner $146 M Jun 28, 2021
Rick Yang 10%+ Owner $146 M Jun 28, 2021
New Enterprise Associates 17, L.P. 10%+ Owner $146 M Jun 28, 2021
Joshua Makower 10%+ Owner $146 M Jun 28, 2021
Peter W. Sonsini 10%+ Owner $146 M Jun 28, 2021
Edward T. Mathers 10%+ Owner $146 M Jun 28, 2021
Anthony A. Florence Jr. 10%+ Owner $146 M Jun 28, 2021
Mohamad Makhzoumi 10%+ Owner $146 M Jun 28, 2021
Forest Baskett 10%+ Owner $146 M Jun 28, 2021
Cormorant Asset Management, LP Former 10% Owner $60.8 M Jun 28, 2021
Owen B. Wallace Chief Scientific Officer $100 K Jan 2, 2024
Filip Janku Chief Medical Officer $99.8 K Jan 2, 2024
Edmund Dunn Principal Accounting Officer $53.4 K -$11 K -17.1% Jul 5, 2024
Ali Behbahani Director, 10%+ Owner Jun 12, 2024
Jan Skvarka Director Jun 12, 2024
Alexander Mayweg Director Jun 14, 2023
Anthony M. Manning Director Jun 12, 2024
Kimberly Blackwell Director Jun 12, 2024
Christine Siu Director Jun 12, 2024
Andrew N. Schiff Director Jun 12, 2024
Jennifer Champoux Chief Operating Officer Jun 3, 2024
Sharon Townson Chief Scientific Officer Jun 3, 2024
Markus Warmuth President & CEO, Director Jan 2, 2024
John C. Castle Chief Data Scientist Jan 3, 2023
Chandra P. Leo Director Jun 23, 2021
Ajim Tamboli Chief Financial Officer Jan 3, 2023
Jullian G. Jones Chief Business Officer Jan 2, 2024
Philip Nickson Chief Business & Legal Officer Jun 3, 2024

Recent Insider Transactions by Companies or Individuals for Monte Rosa Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership